Desire starts in the brain

Online telehealth consultation with free rush delivery direct from our licensed pharmacy.
PT-141 Injectable

Select option

First month $110.00
Then $175/mo recurring
Online consultation
US-licensed physicians
Discreet delivery
couple park and piggy back with smile portrait a utc
Confidential online consultation
Board-certified Physicians
Fast, free shipping
Confidential online consultation
Board-certified Physicians
Fast, free shipping

What is PT-141?

happy hispanic latino couple dating outdoors utc

PT-141 (Bremelanotide) is a compounded prescription treatment option that acts on melanocortin receptors in the central nervous system rather than relying primarily on blood-flow pathways.

It may be considered by a licensed healthcare provider when evaluating concerns related to sexual desire. Your provider will review your symptoms, health history, medications, and treatment goals to determine whether PT-141 is appropriate for you.

Add to Cart
Pharmazee does not manufacture compounded medications. Actual product appearance and labeling of the medication you receive may differ from website images. This is a compounded medication and is not FDA-approved.

Get prescription medications tailored for you in 3 easy steps

1
Fill in a brief health assessment form, 100% online
young bearded man with smartphone in hands reading utc
2
Our board-certified physicians will review your answers and determine if a prescription is right for you.
acbdfdabcceafbbbbac
3
Fast, free delivery if granted a prescription
woman receiving parcel box from delivery man at th utc
Add to Cart
The Doctor Mission - Doctor Webflow Template (1)
Pharmazee

Why choose us?

US-licensed professionals

Experienced healthcare providers committed to your well-being.

Dedicated team

A team passionate about guiding you towards optimal treatment for your health Conditions.

Thoughtfully Packaged

Discreet Deliveries, your privacy comes first
Add to Cart

Frequently asked questions

PT-141 (Bremelanotide) is a compounded prescription treatment option that acts on melanocortin receptors in the central nervous system rather than relying primarily on blood-flow pathways.

It may be considered by a licensed healthcare provider when evaluating concerns related to sexual desire. Your provider will review your symptoms, health history, medications, and treatment goals to determine whether PT-141 is appropriate for you.

PT-141 acts on melanocortin receptors in the central nervous system.

  1. Central Nervous System Activity
    PT-141 activates melanocortin-receptor pathways associated with the body’s sexual-response signaling.
  2. Different From Blood-Flow Medications
    PT-141 has a different mechanism from PDE5 inhibitors such as sildenafil and tadalafil, which act primarily through vascular and nitric-oxide pathways.
  3. Prescription Injection
    PT-141 is administered by subcutaneous injection. Your prescriber will provide individualized instructions regarding the dose, timing, and frequency of use.

PT-141 is administered by subcutaneous injection according to an individualized prescription. Your provider will tell you:

  • The amount to inject
  • When to administer it
  • The maximum permitted frequency
  • Whether it should be used as needed or on another schedule

Individual response, onset, and duration may vary. Follow your prescription label and do not repeat a dose or exceed the prescribed frequency.

Tell your provider if you use testosterone therapy, hormone therapy, sildenafil, tadalafil, or other medications for sexual health. Your provider will determine whether they can be used together safely.

Possible side effects may include:

  • Nausea
  • Flushing or warmth
  • Headache
  • Injection-site reactions
  • Fatigue
  • Dizziness

PT-141 may temporarily increase blood pressure. Changes in skin or gum pigmentation may also occur with repeated use.

This is not a complete list of potential side effects. Contact your prescriber if you experience persistent or concerning symptoms, and seek urgent medical attention for severe symptoms.